3PARL® consortium welcomes Pharma Audit in its mission to assure consistent high standard of GMP supply chain audits in the life sciences industry
Stevenage, UK – January 4th, 2024 – Rephine, the experts in quality assurance & GxP compliance across pharmaceutical, biotech & medical device
manufacturing supply chains, has announced that pharma-audit, specialists for GMP and GDP audits, has joined its trailblazing international consortium that will set a clear standard for life sciences manufacturing supply chain audits globally.
The new Third-Party Audit Report Library (3PARL®) consortium, spearheaded by Rephine and Eurofins Healthcare aims to set a new benchmark for consistent, reliable, high-quality supply chain Good Manufacturing Practice (GMP) audit services and library reports.
pharma-audit, which performs audits from initial planning to the evaluation of corrective measures in all GxP regulated areas, will commit to the same standards and best practices espoused by 3PARL, coming together to collectively set a new benchmark for supply chain audits across the global life sciences industry. This approach assures all stakeholders of the same consistent and compliant rigour and audit quality, from raw material to finished product – whether that’s via a commissioned independent audit, or access to a valid, credible and comprehensive library report.
Commenting on pharma-audit’s membership, Adam Sherlock, Rephine’s CEO, said: “pharma-audit joining 3PARL is a demonstration of why this consortium is so important. In terms of the 3PARL membership, we are also currently in advanced discussions with a number of the leading independent and best-reputed competitors around the world so expect further similar announcements in the next few months. We will continue to grow 3PARL and make it a leading source of authority and trust within the pharma industry.”
Bernd Hasken, Head of pharma-audit, adds: “Trust between clients and auditors is critically important to our industry. That’s why initiatives like 3PARL can strengthen the whole profession, while contributing to patient safety and ensuring product quality. We look forward to working with Rephine and other partners in this endeavour in the coming year.”
To find out more about 3PARL and how you can get involved please email [email protected]
Rephine is a firm of deeply experienced GxP consultants, auditors and practitioners. The company proactively helps pharmaceutical, biotech and medical device companies with all aspects of their manufacturing and supply chain quality assurance and associated business process optimisation.
Widely acknowledged to be the gold standard in its field, Rephine has been providing these specialist quality assurance services for more than 25 years. Rephine is a founding member of 3PARL®, a consortium that aims to set a new benchmark for consistent, reliable, high-quality supply chain Good Manufacturing Practice (GMP) audit services and library reports.
About Pharma Audit
pharma-audit is a brand of Heacon Service GmbH, a daughter company of the BPI e.V. (Federal Association of Pharmaceutical Industry) located in Berlin, Germany. Heacon provides several services specific for pharmaceutical companies such as pharmacovigilance, procurement cooperation, training and third-party audits.
pharma-audit conducts audits in all GxP regulated areas – individually or as part of a shared audit. With its clear and high-quality reports, resulting from an efficient and effective Quality Management approach, and a proven record of accomplishment of customer commitment, it meets all official requirements. The pharma-audit team of qualified and experienced auditors, available worldwide, responds flexibly to client needs and guarantees quick and easy processing.
More at www.pharma-audit.com
Press contacts for Rephine
Carina Birt, Sarum Life Sciences, 07970 006624, [email protected]